Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Henry Schein, Inc.    HSIC

HENRY SCHEIN, INC.

(HSIC)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • In a short-term perspective, the company has interesting fundamentals.
Strengths
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
  • The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
  • The stock is close to a major daily resistance at USD 72.06, which should be gotten rid of so as to gain new appreciation potential.
  • According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart
Sector Medical Equipment Wholesale
1st jan.Capitalisation (M$)Investor Rating
HENRY SCHEIN, INC.9.13%10 027
CANTEL MEDICAL CORP.-0.67%3 149
PATTERSON COMPANIES17.45%2 179
SHIP HEALTHCARE HOLDINGS, I..20.13%2 026
AS ONE CORPORATION33.15%1 690
-
MERIT MEDICAL SYSTEMS, INC.-47.52%1 617
TOKAI CORP.8.43%990
JAPAN MEDICAL DYNAMIC MARKE..108.65%539
OWENS & MINOR, INC.21.33%483
More Results
Financials (USD)
Sales 2019 9 960 M
EBIT 2019 725 M
Net income 2019 500 M
Debt 2019 1 003 M
Yield 2019 -
P/E ratio 2019 20,3x
P/E ratio 2020 18,5x
EV / Sales2019 1,11x
EV / Sales2020 1,05x
Capitalization 10 027 M
Upcoming event on HENRY SCHEIN, INC.
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes